Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Cancer Science|September 1, 2022
Alvocidib inhibits IRF4 expression via super-enhancer suppression and adult T-cell leukemia/lymphoma cell growthHikaru Sakamoto, Koji Ando, Yoshitaka Imaizumi, et al.
Cancer Medicine|October 7, 2016
Expression of Tim-1 in primary CNS lymphomaWataru Kishimoto, Momoko Nishikori, Hiroshi Arima, et al.
Oncotarget|February 9, 2018
Hepatitis C virus infection is an independent prognostic factor in follicular lymphomaJoji Shimono, Hiroaki Miyoshi, Takeharu Kato, et al.
International Journal of Hematology|July 1, 2023
Treatment of new-onset primary central nervous system lymphoma in elderly patients using RMPV chemotherapy: a single-institution experienceMichiharu Yoshida, Takeharu Kato, Takeshi Hiu, et al.
Leukemia Research Reports|May 8, 2019
Successful outcome of second allogeneic bone marrow transplantation for blastic plasmacytoid dendritic cell neoplasm with <i>MYC</i> locus rearrangementTakeharu Kato, Hidehiro Itonaga, Jun Taguchi, et al.
Transplant Immunology|May 31, 2021
The response-guided ATG treatment provides a survival benefit and KPS recovery for patients with steroid refractory acute GVHD: The Nagasaki Transplant Group ExperienceMachiko Fujioka, Hidehiro Itonaga, Takafumi Furumoto, et al.
Internal Medicine (Tokyo, Japan)|May 17, 2023
An Iron-chelating Agent Improved the Cardiac Function in a Patient with Severe Heart Failure Due to Hereditary HemochromatosisAkito Setoguchi, Hiroaki Kawano, Shinji Okano, et al.
The Journal of Pathology|February 6, 2016
CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosisNoriaki Yoshida, Hiroaki Miyoshi, Takeharu Kato, et al.
Leukemia & Lymphoma|September 2, 2024
RUNX1 expression is regulated by a super-enhancer and is a therapeutic target in adult T-cell leukemia/lymphomaYuji Kobayashi, Koji Ando, Yoshitaka Imaizumi, et al.
International Journal of Hematology|June 27, 2020
Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant GroupSachie Kasai, Hidehiro Itonaga, Daisuke Niino, et al.
Pageof 12